Single intramuscular injection of one dose (2 ml), irrespective of body weight.
For reconstitution, transfer the entire content of the solvent vial to the vial containing the lyophilisate and reconstitute the lyophilisate as follows: 10 doses in 20 ml, 50 doses in 100 ml and 100 doses in 200 ml of the solvent.
Ensure that the lyophilisate is completely reconstituted before use.
Visual appearance after reconstitution: clear, colourless suspension.
Avoid introduction of contamination during use.
Use sterile equipment.
Avoid multiple broaching, for example by using automatic injectors.
Regime of vaccination:
Gilts: for protection against PRRSV during pregnancy vaccination is recommended before integration into the sow herd between 2 and 5 weeks prior to breeding. Gilts can then be subjected to the same vaccination programme as the sow herd.
Sows: mass vaccination is recommended in a whole herd programme, in which all the pregnant and non-pregnant sows in the herd are vaccinated every three to four months.
Mixing with ReproCyc ParvoFLEX:
The full content of one vial of ReproCyc ParvoFLEX should be used to reconstitute the lyophilisate of one vial of ReproCyc PRRS EU. ReproCyc ParvoFLEX hereby replaces the solvent of ReproCyc PRRS EU.
Ensure that the lyophilisate is completely reconstituted before use.
Administer a single dose (2 ml) of the mixture intramuscularly.
The following corresponding presentations (doses) can be mixed:
ReproCyc PRRS EU (lyophilisate) | ReproCyc ParvoFLEX |
10 doses | 10 doses (20 ml) |
50 doses | 50 doses (100 ml) |
100 doses | 100 doses (200 ml) |
The package leaflet of ReproCyc ParvoFLEX should also be consulted before the administration of the mixed product.